Calumet Specialty Products Partners LP (CLMT) faced a significant sell-off on Tuesday, with its stock plummeting 16.79% amid heavy bearish options trading activity and an analyst price target downgrade.
The options market saw a surge in bearish bets against CLMT, with put options trading at 7 times the expected level. The most actively traded contracts were the February 2025 $16 and $12 put options, suggesting traders were positioning for further downside in the stock.
Additionally, UBS lowered its price target on CLMT from $24 to $20.50, while maintaining a Neutral rating on the stock. Despite the overall "Overweight" rating from analysts tracked by FactSet, with an average price target of $26.80, the downgrade likely added to the selling pressure on the stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.